Impact of EU Referendum vote on gene and cell therapy in the UK
4 Oct 2016, 1:58 p.m.
In a new editorial published in Human Gene Therapy, leading researchers call for urgent action to ensure continued access to critical funding and ongoing collaborative opportunities with the broader scientific community in the European Union.
Identification of biomarker which could aid risk stratification in Juvenile Dermatomyositis
16 Sep 2016, 11:12 a.m.
Research led by BRC-funded Professor Lucy Wedderburn has shown that muscle pathology and myositis-specific antibodies (MSA) predict the risk of remaining on treatment in Juvenile Dermatomyositis (JDM). These findings could aid risk stratification.
Research demonstrates clinical and economic benefits of implementing NIPT into NHS care pathway
16 Sep 2016, 11:10 a.m.
The UK National Screening Committee, based on a research programme led by BRC-funded Professor Lynn Chitty, has recommended to the Government that NIPT for Down’s Syndrome be implemented into the NHS maternity care pathway and is currently awaiting minist
Construction underway of Zayed Centre featuring new ‘cleanrooms’ for the production of gene and cell therapy medicinal products
16 Sep 2016, 11:06 a.m.
The Zayed Centre for Research into Rare Disease in Children (ZCR) is currently under construction in Guildford Street. Importantly this will include a dedicated facility comprising seven ‘cleanrooms’ where gene and cell therapy medicinal products can be m
SCIDNET is a European Commission Horizon 2020 -funded project which launched in January 2016. It aims to take gene therapy from current clinical trials to a medicinal product that can be delivered to any child in the EU. It follows on from previous EU col